VALGANCICLOVIR HYDROCHLORIDE is a Oral For Solution in the Human Prescription Drug category. It is labeled and distributed by Somerset Therapeutics, Llc. The primary component is Valganciclovir.
Product ID | 70069-810_b856bfaf-ec6b-4171-81c4-b9b07f780084 |
NDC | 70069-810 |
Product Type | Human Prescription Drug |
Proprietary Name | VALGANCICLOVIR HYDROCHLORIDE |
Generic Name | Valganciclovir |
Dosage Form | For Solution |
Route of Administration | ORAL |
Marketing Start Date | 2022-01-15 |
Marketing Category | ANDA / |
Application Number | ANDA213306 |
Labeler Name | Somerset Therapeutics, LLC |
Substance Name | VALGANCICLOVIR |
Active Ingredient Strength | 50 mg/mL |
Pharm Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog [EXT] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-01-15 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
27241-159 | Valganciclovir hydrochloride | Valganciclovir hydrochloride |
43598-356 | valganciclovir hydrochloride | valganciclovir hydrochloride |
63739-357 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE |
65862-753 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE |
70010-051 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE |
0004-0038 | Valcyte | valganciclovir |
0004-0039 | Valcyte | valganciclovir hydrochloride |
0603-6330 | Valganciclovir | Valganciclovir hydrochloride |
0904-6796 | Valganciclovir | Valganciclovir |
16714-765 | Valganciclovir | Valganciclovir |
27241-158 | Valganciclovir | Valganciclovir |
31722-832 | Valganciclovir | Valganciclovir |
31722-837 | VALGANCICLOVIR | VALGANCICLOVIR HYDROCHLORIDE |
42291-875 | Valganciclovir | Valganciclovir hydrochloride |
48433-124 | Valganciclovir | Valganciclovir |
50268-787 | Valganciclovir | Valganciclovir |
0591-2579 | Valganciclovir hydrochloride for Oral | Valganciclovir hydrochloride |